Fund Name | Location |
Arafura Ventures | California, Palo Alto, United States |
Carlton Communications | England, London, United Kingdom |
DS Investment Management Co.,Ltd | Seoul, Seoul-t'ukpyolsi, South Korea |
E-nicial Ventures | New York, New York, United States |
German Ventures | Bayern, Germany, Munich |
Grupara Ventures | Indonesia, Jakarta, Jakarta Raya |
Hunan Hi-Tech Venture Capital | China, Fujian, Hunan |
LUMA Capital Partners | New York, New York, United States |
Michigan Department of Transportation | Lansing, Michigan, United States |
RedHouse Associates | Houston, Texas, United States |
Schmidt Futures | New York, New York, United States |
SI Securities, LLC | - |
Steadfast Venture Capital | New York, New York, United States |
Techbridge International | Chelmsford, Massachusetts, United States |
Twin Brook Capital Partners | Chicago, Illinois, United States |
Vimac Ventures | Boston, Massachusetts, United States |
West Hill Capital | England, London, United Kingdom |
Willsun Capital | China, Guangdong, Guangzhou |
Wobbly-Door Ventures | California, Palo Alto, United States |
Yongjin Group | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
PreciseDx | $20M | 21 Aug 2024 | New York, New York, United States | ||
Universal Diagnostics | 19 Aug 2024 | Seville, Andalucia, Spain | |||
Universal Diagnostics | $75M | 20 Nov 2023 | Seville, Andalucia, Spain | ||
Lemonaid Health | $11M | 22 May 2017 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
PreciseDx | $20M | 21 Aug 2024 | New York, New York, United States | ||
Universal Diagnostics | 19 Aug 2024 | Seville, Andalucia, Spain | |||
Universal Diagnostics | $75M | 20 Nov 2023 | Seville, Andalucia, Spain | ||
Lemonaid Health | $11M | 22 May 2017 | San Francisco, California, United States |